ASXFDA-CVM Establish INAD File for CannEpil Veterinary Program
other announcement
Health (HEA) News
Latest articles and price-sensitive announcements with AI sentiment classification.
$250,000 in Funding Received under Financing Facility
other announcement
US Veterinary Development Programme for CannEpil Commences
other announcement
CannEpil Global Licence Expands into Veterinary Healthcare
other announcement
Quarterly Activities/Appendix 4C Cash Flow Report
other announcement
StockheadIain Wilkie, for Scott Power: Healthcare lifts as FDA moves to stamp out peptide black market
ASX healthcare stocks fall for week ending July 17, 2026; TTX could benefit from US FDA looking to ease restrictions ... Read More The post Iain Wilkie, for Scott Power: Healthcare lifts as FDA moves to stamp out peptide black market appeared first on Stockhead.
Motley FoolThis healthcare stock just jumped 15% and experts are tipping a further 80% rise
Momentum is building for this exciting stock. The post This healthcare stock just jumped 15% and experts are tipping a further 80% rise appeared first on The Motley Fool Australia.
Notification regarding unquoted securities - RGT
other announcement
$350,000 in Funding Received under Financing Facility
other announcement
RGT Executes Global CannEpil Licensing Deal for US$5.5M
other announcement
KalkineThe Smallcap Stocks Story Readers Are Tracking As Health Tech Proof Builds
Highlights Health tech proof is shifting attention toward patient access, validation and channel execution. Botanix Pharmaceuticals (ASX:BOT), Orthocell (ASX:OCC) and AnteoTech (ASX:ADO) show different ways the theme is appearing on the ASX screen. The current setup favours revenue pathways beside technical progress over broad sector excitement. The latest ASX setup is putting healthcare-focused smaller companies through a sharper test as the market looks beyo...
Why Healthcare Stocks Are Back In Focus As Rebound Quality Test Takes Over
Highlights • Healthcare shares are drawing renewed attention as markets place greater emphasis on earnings quality, resilient cash flow and disciplined execution. • CSL (ASX:CSL), ResMed (ASX:RMD), Pro Medicus (ASX:PME) and Cochlear (ASX:COH) are emerging as key reference points for the sector's changing narrative. • A more selective Australian market is rewarding evidence-based business performance rather than broad sector momentum. ...
Why Is Halma (LSE:HLMA) Expanding Its Healthcare Portfolio With New Acquisitions?
Highlights Healthcare portfolio expands through two strategic acquisitions. New technologies strengthen digital healthcare and cancer treatment capabilities. Expansion supports broader healthcare innovation across global markets. Halma (HLMA) has expanded its healthcare business through two new acquisitions, adding hospital software and cancer treatment technologies while strengthening its presence in medical innovation and patient c...
Best Health Stocks to Watch for July 2026
Highlights CSL Ltd (ASX:CSL), Sonic Healthcare Ltd (ASX:SHL), TELIX Pharmaceuticals Ltd (ASX:TLX), Ansell Ltd (ASX:ANN), EBOS Group Ltd (ASX:EBO) and Mesoblast Ltd (ASX:MSB) remain among the closely followed Australian healthcare companies. Healthcare continues benefiting from long-term themes including ageing populations, medical innovation, diagnostics and biotechnology. Product development, regulatory milestones and commercial execution remain key drivers across th...
Google NewsAI Healthcare Stocks With Real Revenue And Big Growth Gaps - simplywall.st
AI Healthcare Stocks With Real Revenue And Big Growth Gaps simplywall.st
Closing Bell: Tech flexes as healthcare muscles through June
Tech and healthcare gave the ASX another lift as investors looked past global jitters, while peace talks returned to the ... Read More The post Closing Bell: Tech flexes as healthcare muscles through June appeared first on Stockhead.
AI Healthcare Stocks: Why Validation May Matter More Than The Hype Cycle
Highlights On 29 June, the [ASX 200] opened firmer after a volatile prior week, but the market tone remained selective. Pro Medicus (ASX:PME), Echo IQ (ASX:EIQ), WiseTech Global (ASX:WTC) and Nuix (ASX:NXL) highlight different AI validation angles. The key screen is shifting from AI excitement to evidence, workflow adoption and commercial execution. Artificial intelligence remains one of the most watched themes on the ASX, but the healthcare sid...
Health Kick Podcast: Supermarket success brings Calmer Co to flavour country
Tim Boreham catches up with Calmer Co CEO Zane Yoshida to discuss the company's ever-expanding reach into a kava sector enjoying ... Read More The post Health Kick Podcast: Supermarket success brings Calmer Co to flavour country appeared first on Stockhead.
WFH is linked to worse mental health – but it’s a big boost for some
Some remote workers go days without human contact and many have worse mental health, according to one study. But experts say that link is tenuous, with strong benefits for some groups.
Women’s health platform Ovum triples valuation to $18m in a year after $4m seed round
Australian women’s health startup Ovum has backed up a $1.7 million pre-seed round a year ago with $4 million in seed funding to address what it sees as a “trillion-dollar women’s health gap”. The latest seed round has been struck at triple the earlier valuation, pricing Ovum's total capital at $18 million. The...
Health Check: Woundcare house tackles overlooked women’s cancer sector
Tetratherix and its joint venture partner will launch an expanded study of its innovative spacer, to protect female cancer patients ... Read More The post Health Check: Woundcare house tackles overlooked women’s cancer sector appeared first on Stockhead.
Defensive Growth Rotation Is Putting Healthcare Back in the Spotlight
Highlights Defensive growth themes are drawing fresh attention towards ASX healthcare companies as market leadership continues to rotate. CSL, Pro Medicus, Telix Pharmaceuticals and Cochlear are emerging as key names being watched for earnings quality and business execution. Cash flow strength, balance-sheet resilience and revenue visibility remain the critical factors separating stronger healthcare businesses from broader market noise. Australia's equity market is navigating a period o...
Transformative AI Healthcare Stocks Backed By An Unusual Cash Cushion - simplywall.st
Transformative AI Healthcare Stocks Backed By An Unusual Cash Cushion simplywall.st
Healthcare's Split Decision: Why Medtech and Software Stocks Are Taking Different Paths
Highlights Healthcare stocks are attracting renewed attention as investors assess defensive growth opportunities ahead of key market events. Medical device manufacturers and healthcare software providers are responding differently to the current market environment. Earnings visibility, customer demand and valuation discipline remain central themes shaping the sector. ASX healthcare stocks are drawing renewed attention as investors compare the growth potential, valuation outlook and earnings v...
EZZ-backed research highlights compound’s role in healthy ageing
A University of Auckland review proposes that three compounds associated with healthy ageing may act more effectively in combination. ... Read More The post EZZ-backed research highlights compound’s role in healthy ageing appeared first on Stockhead.
Telix's New Healthcare Collaboration Sparks Fresh Market Discussion
Highlights Telix Pharmaceuticals signed a new collaboration agreement with United Imaging Healthcare North America. The partnership aims to explore integrated theranostics workflows in the United States healthcare market. The agreement strengthens Telix's position as it expands its molecular imaging and therapeutic ecosystem. Telix Pharmaceuticals strengthened its precision medicine strategy through a new healthcare collaboration that combines imaging technologies, artificial intelligence too...
Healthcare Stocks Back in Focus as Device and Diagnostics Trends Gain Attention
Highlights Device and diagnostics trends remain a key healthcare theme. Healthcare leaders continue attracting market attention. Procedure demand and cash flow visibility stay important. Healthcare stocks are drawing renewed interest as device and diagnostics activity strengthens sector attention. Market participants are closely monitoring demand trends, cash flow visibility, and operational execution across leading healthcare companies listed on the ASX. Healthcare Stocks are once agai...
Healthcare Stocks Back In Focus As Market Searches For Stability
Highlights Healthcare regains attention amid shifting market sentiment. Earnings resilience remains a key sector theme. Global demand trends continue shaping sector outlook. Healthcare stocks are once again drawing market attention as investors assess earnings resilience, global demand trends and sector leadership opportunities. Several established healthcare names are helping shape the discussion as the broader Australian market moves beyond a short-term rebound and focuses on sustaina...
Health Kick Podcast: Aroa prepares for next growth phase on record revenue
Aroa Biosurgery is focused on its next phase of growth. CFO James Agnew joins Tim Boreham to discuss. ... Read More The post Health Kick Podcast: Aroa prepares for next growth phase on record revenue appeared first on Stockhead.
Healthcare Stocks Nobody Can Ignore as Valuation Repair Gains Pace
Highlights Healthcare stocks are being reassessed through earnings quality, product adoption, reimbursement trends and margin discipline rather than broad sector enthusiasm. CSL, ResMed and Cochlear remain central to the valuation repair discussion as markets seek stronger operating evidence. Device demand, biotech milestones, software contracts and diagnostic activity could shape sentiment across the sector through the year. The Australian share market is entering a more selective phase, and...
From Trial Hope to Revenue Proof: Why Healthcare Stocks Face a Bigger Test
Highlights Healthcare stocks are increasingly being judged on revenue quality, product adoption, margins and execution rather than market excitement alone. CSL, ResMed and Cochlear remain key reference points as the sector shifts towards commercial proof and operational delivery. Device demand, diagnostic activity, reimbursement settings and clinical milestones are emerging as major sentiment drivers across the healthcare sector. The Australian share market is taking a closer look at healthca...
Why Are These Healthcare Stocks Capturing Market Attention?
Highlights Seven healthcare companies remain among the most discussed names across Australia's healthcare sector. Medical technology, diagnostics, healthcare services, and biotechnology continue shaping sector activity. Several featured companies maintain representation across major Australian market benchmarks. Seven healthcare companies spanning biotechnology, diagnostics, hospitals, medical devices, and healthcare software continue drawing attention across Australia's healthcare sector and...
Which Healthcare Leader Commands More Attention Now?
Highlights CSL Limited (ASX:CSL), Cochlear (ASX:COH), ResMed (ASX:RMD) and Sonic Healthcare (ASX:SHL) remain among the most influential healthcare names on the Australian market. Revenue quality, healthcare demand, product adoption, service expansion and operational discipline continue to shape attention across the sector. Healthcare technology, diagnostics, medical devices and biotechnology remain central themes influencing sector discussions. Leading ASX healthcare companies continue ...
The Market’s Quiet Achiever: Why Healthcare Keeps Winning
Highlights Healthcare combines defensive stability with long-term growth drivers. Ageing populations continue to support demand for medical products and services. Australian healthcare stocks range from global leaders to innovative growth-focused businesses. Australia’s share market is home to many sectors that thrive during economic booms, but few can offer resilience when conditions become uncertain while still delivering meaningful long-term expansion. That rare combination is ...
Healthcare's Hidden Comeback Story Few Saw Coming
Highlights Australian healthcare shares endured one of their toughest periods as currency pressures, rising costs and tariff concerns weighed on sentiment. CSL, Cochlear and ResMed faced heavy selling despite retaining strong positions in their respective healthcare markets. Long-term industry drivers including ageing populations and increasing healthcare demand remain firmly intact. Australia's leading healthcare companies faced significant pressure from costs, currency movements and market ...
Is this exciting healthcare stock a buy, hold or sell after rocketing 16% yesterday?
Can this soaring stock keep rising? The post Is this exciting healthcare stock a buy, hold or sell after rocketing 16% yesterday? appeared first on The Motley Fool Australia.
Healthcare's Hidden Opportunity: Why the Sector Has Eyes on a Revival
Highlights ASX healthcare stocks endured a sharp sector-wide decline as earnings downgrades and shifting market sentiment weighed on valuations. Leading healthcare names including CSL, Cochlear, ResMed and Pro Medicus faced heavy pressure despite retaining strong industry positions. Long-term healthcare demand drivers remain intact, keeping the sector firmly on watchlists across the Australian market. Australia's healthcare sector faced a difficult period as earnings setbacks and shifting sen...
Why Are Healthcare Stocks Drawing Sharper Market Focus?
Highlights ASX healthcare stocks are being shaped by clinical milestones, diagnostics activity, device innovation and global demand. ResMed (ASX:RMD), Sonic Healthcare (ASX:SHL), Pro Medicus (ASX:PME), Telix Pharmaceuticals (ASX:TLX) and CSL (ASX:CSL) reflect diverse healthcare business models. Market attention is increasingly focused on operational execution, commercial progress and healthcare innovation themes. ASX healthcare stocks remain in focus as clinical milestones, diagnostics ...
CSL’s Sharp Rebound Raises A Bigger Question For The Healthcare Giant
Highlights CSL shares rebounded strongly at the end of last week amid renewed interest in healthcare stocks. Recent earnings guidance revisions and impairment announcements continue to shape market sentiment. Investors remain focused on how CSL navigates operational challenges across its key business divisions. CSL rebounded strongly alongside the broader healthcare sector, though investors continue assessing operational challenges, earnings momentum and the company’s ongoing strategic ...
'Almost dying wasn't on my bingo card': Biles reveals 'scariest' health scare
Decorated gymnast Simone Biles shares an undisclosed health scare, telling her social media followers that "almost dying wasn't on my bingo card earlier this week".
The Hidden Forces Quietly Shaping Healthcare Stocks
Highlights Healthcare companies are being influenced by shifting demand patterns, regulatory developments and global healthcare spending trends. Leading names including CSL (ASX:CSL), ResMed (ASX:RMD) and Cochlear (ASX:COH) highlight the diversity within the sector. Market attention is increasingly focused on catalysts beneath the surface rather than headline narratives alone. Australia's share market is constantly searching for its next compelling theme, and healthcare has re-emerged a...
Healthcare’s Biggest Sell-Off Could Be Creating New Opportunities
Highlights Healthcare has emerged as one of the weakest-performing sectors on the Australian market this year. Several leading healthcare companies have experienced significant share price declines despite ongoing business developments. ResMed, Fisher & Paykel Healthcare, and Pro Medicus remain among the sector's most closely watched names. Healthcare remains one of the weakest-performing sectors this year, with major companies facing pressure despite ongoing operational and industry deve...
‘Back soon’: RFK Jr-inspired health start-up goes offline
Bobbi, a telehealth provider named after the US Health Secretary has taken down its website after this masthead’s reporting on its prescribing practices.
Why CSL’s Sharp Slide Is Putting the Healthcare Giant Back in Focus
Highlights CSL shares have faced significant pressure despite the company’s strong global healthcare position. The biotechnology group continues benefiting from defensive healthcare demand and diversified operations. Market attention is now centred on valuation, growth execution, and long-term healthcare trends. CSL shares remain closely watched as the biotechnology giant navigates valuation pressure and long-term healthcare growth trends. CSL Limited (ASX:CSL) remains one of Australia&...
Why Healthcare Stocks Keep Drawing Market Attention
Highlights Healthcare companies span pharmaceuticals, biotechnology, medical devices, diagnostics and healthcare services across diverse business models. Australia hosts globally recognised healthcare leaders with expanding international operations and innovation pipelines. Ageing populations, medical innovation and rising healthcare demand continue supporting long-term sector relevance. Healthcare stocks continue attracting market attention through demographic growth, biotechnology inn...
Health Check: Kiwi health heroes wander offshore chasing growth
Unlike perennially grounded Kiwi birds, New Zealand's healthcare leaders are taking flight after a round of well-received profit results. ... Read More The post Health Check: Kiwi health heroes wander offshore chasing growth appeared first on Stockhead.
Healthcare Giant Surges After Strong FY26 Earnings Beat
Highlights Fisher & Paykel Healthcare delivered strong revenue and profit growth across hospital and homecare divisions. Respiratory care products and sleep apnoea therapies continued driving global demand momentum. Investors responded positively as earnings growth and FY27 guidance boosted sentiment across the [ASX 200]. Fisher & Paykel Healthcare surged after delivering strong FY26 earnings growth, improving margins, and continued momentum across respiratory care and sleep therapy m...
Why This Healthcare Giant Is Surging On FY26 Results
Highlights Strong hospital product demand and improving margins lifted earnings growth for the healthcare company. Respiratory care and sleep apnoea product lines continued supporting global revenue expansion. Investor confidence strengthened after upgraded earnings guidance and operational momentum across the [ASX 200]. Fisher & Paykel Healthcare shares surged after strong FY26 earnings, improving margins, and continued growth across respiratory care and sleep therapy markets. Fisher &am...
Healthcare innovation pours into the Yarra Valley
This year’s Stocks in the Vines event put healthcare innovation in focus, connecting investors with ASX-listed and emerging healthcare companies. ... Read More The post Healthcare innovation pours into the Yarra Valley appeared first on Stockhead.
Why This Aussie AI Healthcare Stock Is Expanding Fast
Highlights IMEXHS strengthened its international healthcare footprint with an AI radiology rollout in Mexico. The expansion highlighted growing demand for AI-powered medical imaging solutions globally. Australian health technology companies continued attracting attention as digital healthcare adoption accelerated. IMEXHS expanded its AI radiology technology deployment into Mexico, reflecting growing international demand for digital healthcare infrastructure and artificial intelligence-p...
If AI Healthcare Really Scales, These Three Stocks Could Surprise - simplywall.st
If AI Healthcare Really Scales, These Three Stocks Could Surprise simplywall.st